| Multi-Centre Study to Assess the Long-term Performance of the DePuy ASR™ System in Resurfacing and Primary Total Hip Replacement (NCT00872547) | DePuy International | 2006-09-01 |
| Etanercept and Methotrexate in Patients to Induce Remission in Early Arthritis (EMPIRE) (NCT01303874) | University of Leeds | 2006-09-01 |
| SMART Study: A Study of Re-treatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNF Alfa Therapy (NCT01126541) | Hoffmann-La Roche | 2006-09-01 |
| Infliximab as Induction Therapy in Early Rheumatoid Arthritis (IDEA) (NCT01308255) | University of Leeds | 2006-09-01 |
| A Study of Safety and Effectiveness of Golimumab in Participants With Active Rheumatoid Arthritis Despite Methotrexate Therapy (NCT00361335) | Centocor, Inc. | 2006-09-01 |
| Observational Trial With Enbrel (NCT00488475) | Pfizer | 2006-09-01 |
| Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Measure Response to Etanercept in Rheumatoid Arthritis (NCT00361634) | Amgen | 2006-09-01 |
| Long-Term Assessment of Safety and Physical Function With AMG 108 in RA (NCT00369473) | Amgen | 2006-09-01 |
| Clinical Investigation of the LCS® Complete Posterior Stabilized Mobile-bearing Total Knee System (NCT00487565) | DePuy Orthopaedics | 2006-09-01 |
| Abatacept Pregnancy Exposure Registry (NCT01087125) | Bristol-Myers Squibb | 2006-09-01 |
| Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PN 200 or Naproxen in Subjects Who Are at Risk for Developing NSAID-Associated Ulcers. (NCT00367211) | POZEN | 2006-09-01 |
| A Study of MabThera/Rituxan (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis and Inadequate Response to DMARD Therapy (NCT02006706) | Hoffmann-La Roche | 2006-08-10 |
| Treatment of Arthritis With Syk Kinase Inhibition (TASKI-1) (NCT00326339) | Rigel Pharmaceuticals | 2006-08-01 |
| Cardiovascular Outcomes in the VA's Rheumatoid Arthritis(VARA) Population (NCT00431405) | Dallas VA Medical Center | 2006-08-01 |
| I-beam and Cruciate Tibial Components Used in Total Knee Replacement (NCT00588783) | Biomet Orthopedics, LLC | 2006-08-01 |
| Yoga for Rheumatoid Arthritis (NCT00349869) | Johns Hopkins University | 2006-08-01 |
| Evaluation of 2 Oral Doses of PG-760564 in Rheumatoid Arthritis (RA) Patients Receiving Methotrexate (NCT00369928) | Procter and Gamble | 2006-08-01 |
| A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior Anti-TNF Therapy (RESET) (NCT01272908) | Hoffmann-La Roche | 2006-07-18 |
| Effectiveness of Occupational Therapy in Patients With Rheumatoid Arthritis(RCT) (NCT00400868) | University of Zurich | 2006-07-01 |
| An Analysis of Peripheral Blood T Cell Subsets on Rheumatoid Arthritis (NCT00555542) | Chinese University of Hong Kong | 2006-07-01 |
| Study of a Large Protein Molecule Administered With Escalating Doses of Recombinant Human Hyaluronidase (NCT00369187) | Halozyme Therapeutics | 2006-07-01 |
| A Two Centre Study to Assess the Stability and Long-term Performance of the C-Stem™ AMT in a Total Primary Hip Replacement (NCT00872573) | DePuy International | 2006-07-01 |
| Etoricoxib Prescribing Patterns and Adverse Events of Interest in Primary Care in the United Kingdom (MK-0663-162 AM1) (NCT01685424) | Organon and Co | 2006-06-30 |
| Oral CF101 and Methotrexate Treatment in Rheumatoid Arthritis Patients (NCT00280917) | Can-Fite BioPharma | 2006-06-01 |
| Factors Associated With Biologic DMARD Switching (NCT02346942) | Bristol-Myers Squibb | 2006-06-01 |
| A Study of Abatacept in Japanese Patients With Active Rheumatoid Arthritis While Receiving Methotrexate (NCT00345748) | Bristol-Myers Squibb | 2006-06-01 |
| Treatment of Rheumatoid Arthritis With Roxithromycin (NCT00439062) | Nazilli State Hospital | 2006-06-01 |
| PhaseⅢOpen-label Study of MRA for Rheumatoid Arthritis(RA) (NCT00380601) | Chugai Pharmaceutical | 2006-05-01 |
| A 3-year Study Following up Patients With Moderate to Severe Rheumatoid Arthritis Treated With Humira in Greece (NCT01086033) | AbbVie (prior sponsor, Abbott) | 2006-05-01 |
| Safety and Tolerability of Rituxan With Methotrexate and Etanercept or Methotrexate and Adalimumab in Patients With Active Rheumatoid Arthritis (NCT00298272) | Biogen | 2006-05-01 |
| A Double Blind Placebo Controlled Study to Assess the Efficacy on Joint Damage in RA Patients (NCT00319917) | Astellas Pharma Inc | 2006-04-01 |
| A Study of P38 Inhibitor (4) Monotherapy in Patients With Active Rheumatoid Arthritis (NCT00303563) | Hoffmann-La Roche | 2006-04-01 |
| Study Evaluating the Clinical Remission in Early Aggressive Rheumatoid Arthritis (NCT00267852) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-04-01 |
| Determining How the Nervous System Processes Pain in Adults With Fibromyalgia (NCT00496886) | University of Wisconsin, Madison | 2006-04-01 |
| Re³ (Re-Cube: Retain Remicade® Response)(Study P04249AM3) (NCT00394589) | Merck Sharp & Dohme LLC | 2006-03-01 |
| Self-injection of Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis (NCT00603993) | Abbott | 2006-03-01 |
| A Study to Assess the Long-term Performance of SmartSet® HV and SmartSet® GHV Bone Cements in Primary Total Hip Replacement (NCT00872066) | DePuy International | 2006-03-01 |
| A Multiple Dose Study to Evaluate Subcutaneous AMG 108 in Subjects With Rheumatoid Arthritis (NCT00293826) | Amgen | 2006-03-01 |
| Pharmacogenetics of Antifolate Disease Modifying Anti-Rheumatic Drugs in Rheumatoid Arthritis in Taiwan (NCT00944320) | National Chung Hsing University | 2006-02-01 |
| A Non-Comparative Study to Assess the Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis. (NCT00502996) | Hoffmann-La Roche | 2006-02-01 |
| Quality of Sleep in Patients With Rheumatoid Arthritis (NCT00287794) | Kobe University | 2006-02-01 |
| A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA) (NCT00422383) | Hoffmann-La Roche | 2006-02-01 |
| A Clinical Investigation of ArComXL® Polyethylene in Total Hip Replacement (NCT00698152) | Zimmer Biomet | 2006-01-23 |
| A Study to Evaluate the Effects of Rituximab on Immune Responses in Subjects With Active Rheumatoid Arthritis Receiving Background Methotrexate (NCT00282308) | Genentech, Inc. | 2006-01-23 |
| Real-World Emulation of the SWEFOT Trial (NCT05051137) | Karolinska Institutet | 2006-01-12 |
| Study to Assess Steady-State Trough Concentrations, Safety, and Immunogenicity of Abatacept After Subcutaneous (SC) Administration to Subjects With Rheumatoid Arthritis (RA) (NCT00254293) | Bristol-Myers Squibb | 2006-01-01 |
| A Pharmacokinetic and Pharmacodynamic Study of MabThera (Rituximab) Plus Methotrexate in Patients With Rheumatoid Arthritis (RA) (NCT00422942) | Hoffmann-La Roche | 2006-01-01 |
| Efferocytosis and Genomic Polymorphism in Autoimmune Diseases (NCT00364728) | National Taiwan University Hospital | 2006-01-01 |
| An Open-Label Study to Assess the Rate of Failure of an Enbrel® (Etanercept) SureClick™ Auto-injector in Subjects With Rheumatoid Arthritis (NCT00346294) | Amgen | 2006-01-01 |
| Rheumatoid Arthritis Dose Ranging Study (0663-086)(COMPLETED) (NCT00264147) | Organon and Co | 2006-01-01 |
| Predictors of the Response to Adalimumab in Rheumatoid Arthritis (NCT00234234) | University Hospital, Rouen | 2006-01-01 |
| Intra-articular Glucocorticoid Treatment of the Elbow (NCT00972530) | Region Gävleborg | 2006-01-01 |
| Predicting Hospitalized Infection in Patients With Chronic Inflammatory Arthritis Treated With Biological Drugs (NCT03496831) | Simon Krabbe | 2006-01-01 |
| Safety and Effectiveness of Infliximab in Slovakia When Used for Rheumatoid Arthritis (Study P04741)(COMPLETED) (NCT00724243) | Merck Sharp & Dohme LLC | 2006-01-01 |
| A Study of Retreatment With Rituximab in Patients With Rheumatoid Arthritis Receiving Background Methotrexate (NCT00266227) | Genentech, Inc. | 2006-01-01 |
| A Study to Evaluate Rituximab in Combination With Methotrexate in Methotrexate-Naive Patients With Active Rheumatoid Arthritis (NCT00299104) | Genentech, Inc. | 2006-01-01 |
| A Study to Observe Characteristics of Rheumatoid Arthritis in Patients Using Infliximab (Study P04250) (NCT00705289) | Merck Sharp & Dohme LLC | 2005-12-01 |
| An Efficacy and Safety Study of Golimumab in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy (NCT00264550) | Centocor, Inc. | 2005-12-01 |
| Double Blind, Placebo-controlled, Study of the Safety, Tolerability and Pharmacokinetics of AIN457 in Rheumatoid Arthritis Patients (NCT00669942) | Novartis Pharmaceuticals | 2005-12-01 |
| A Study of the Safety and Efficacy of Golimumab in Subjects With Rheumatoid Arthritis That Are Methotrexate-naive (NCT00264537) | Centocor, Inc. | 2005-12-01 |
| A Study of the Safety and Effectiveness of Liquid Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis (NCT00160641) | UCB Pharma | 2005-11-01 |
| Multiple Ascending Dose Study of BMS-582949 in Patients With Stable Rheumatoid Arthritis on the Methotrexate Background (NCT00162292) | Bristol-Myers Squibb | 2005-11-01 |
| A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy (NCT00316771) | Hoffmann-La Roche | 2005-11-01 |
| Identification of Cytokine Profiles and T Cell Subsets Among Immunosuppressed Patients at Risk of Developing Active Tuberculosis (NCT00285441) | Hvidovre University Hospital | 2005-11-01 |
| Dose-Escalating Study of BG9924 in Combination With Methotrexate in Active Rheumatoid Arthritis (NCT00292422) | Biogen | 2005-11-01 |
| Development and Evaluation of A Mailed Arthritis Self-Management Program (NCT00448474) | University of North Carolina | 2005-11-01 |
| Long-Circulating Liposomal Prednisolone Versus Pulse Intramuscular Methylprednisolone in Patients With Active Rheumatoid Arthritis (NCT00241982) | Radboud University Medical Center | 2005-10-01 |
| Enbrel Liquid Immunogenicity Protocol (NCT00249041) | Amgen | 2005-10-01 |
| A Study of Ocrelizumab in Participants With Moderate to Severe Rheumatoid Arthritis (RA) (NCT02720120) | Hoffmann-La Roche | 2005-10-01 |
| The Effect of Rituximab on the Humoral Response to Influenza Vaccine (NCT00466037) | Tel-Aviv Sourasky Medical Center | 2005-09-01 |
| An Extension Study of Tocilizumab (Myeloma Receptor Antibody [MRA]) in Patients Completing Treatment in Tocilizumab Core Studies (NCT00720798) | Hoffmann-La Roche | 2005-09-01 |
| Efficacy and Safety of Increased Dose of TA-650(Infliximab) in Patients With Rheumatoid Arthritis (NCT00691028) | Tanabe Pharma Corporation | 2005-09-01 |
| Comparison of Adalimumab and Infliximab Treatment of Rheumatoid Arthritis (NCT00216177) | Hvidovre University Hospital | 2005-09-01 |
| Improving Motivation for Physical Activity in Arthritis Clinical Trial (NCT00248105) | Northwestern University | 2005-09-01 |
| A Study of the Safety and Efficacy of Rituximab in Patients With Moderate to Severe Rheumatoid Arthritis Receiving Methotrexate (NCT00243412) | Genentech, Inc. | 2005-08-01 |
| A Multicentre Trial to Determine the Efficacy of AD 452 in RA Subjects. (NCT00141934) | Sosei | 2005-08-01 |
| A Long-term Extension Study of Tocilizumab (Myeloma Receptor Antibody [MRA]) in Patients With Rheumatoid Arthritis (NCT00721123) | Hoffmann-La Roche | 2005-08-01 |
| A Clinical Investigation of the Taperloc® Microplasty™ Hip System (NCT00699309) | Biomet Orthopedics, LLC | 2005-08-01 |
| Study Evaluating ERB-041 With Methotrexate in Rheumatoid Arthritis (NCT00141830) | Wyeth is now a wholly owned subsidiary of Pfizer | 2005-08-01 |
| Decoy Receptor 3 (DcR3) Polymorphisms in Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE) (NCT00172666) | National Taiwan University Hospital | 2005-08-01 |
| A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis (NCT00109408) | Hoffmann-La Roche | 2005-07-01 |
| Remission and Joint Damage Progression in Early Rheumatoid Arthritis (NCT00122382) | Bristol-Myers Squibb | 2005-07-01 |
| A Study of MabThera (Rituximab) in Participants With Rheumatoid Arthritis Who Have Had an Inadequate Response to Disease-Modifying Antirheumatic Drugs (DMARD) and/or Anti-Tumor Necrosis Factor (Anti-TNF) Therapy. (NCT00503425) | Hoffmann-La Roche | 2005-06-30 |
| Efficacy and Safety of Etanercept in Active RA Despite Methotrexate Therapy in Japan (NCT00688103) | Japan Biological Agent Study Integrated Consortium | 2005-06-01 |
| Open-Label Steroid Reduction Study of Adalimumab With Methotrexate in Patients With Active Rheumatoid Arthritis (NCT00233558) | Abbott | 2005-06-01 |
| Phase 2 Clinical Study in Rheumatoid Arthritis With an Investigational Oral p38 MAP Kinase Inhibitor VX-702 (NCT00205478) | Vertex Pharmaceuticals Incorporated | 2005-06-01 |
| Total Knee Replacement With Duracon® and Vanguard™ Prostheses (NCT00588887) | Biomet Orthopedics, LLC | 2005-06-01 |
| A Study of Liquid Certolizumab Pegol as Additional Medication to Methotrexate in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis (NCT00160602) | UCB Pharma | 2005-06-01 |
| A Study of the Safety and Effectiveness of Lyophilized Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis (NCT00175877) | UCB Pharma | 2005-06-01 |
| Evaluating Efficacy and Safety of Etanercept 50 mg Twice Weekly (BIW) in Rheumatoid Arthritis (RA) Subjects Who Are Sub-Optimal Responders to Etanercept 50 mg Once Weekly (QW) (NCT00115219) | Amgen | 2005-05-01 |
| The Effect of Adalimumab (Humira) on Vascular Abnormalities in Rheumatoid Arthritis. A Pilot Study. (NCT01270087) | Skane University Hospital | 2005-05-01 |
| Lingzhi and Sen Miao San for the Treatment of Rheumatoid Arthritis (NCT00432484) | Chinese University of Hong Kong | 2005-05-01 |
| A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy (NCT00106522) | Hoffmann-La Roche | 2005-05-01 |
| Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy (NCT00124982) | Bristol-Myers Squibb | 2005-04-01 |
| Effects of a Rehabilitation Program on Physical Performance and Disease Self-management in Rheumatoid Arthritis. (NCT01307787) | University Medical Center Groningen | 2005-04-01 |
| A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis (NCT00106574) | Hoffmann-La Roche | 2005-04-01 |
| Co-Administration Of Methotrexate And CP-690,550 (NCT01745055) | Pfizer | 2005-04-01 |
| Safety Study of Abatacept to Treat Rheumatoid Arthritis (B) (NCT01088360) | Bristol-Myers Squibb | 2005-03-31 |
| Rheumatic Diseases and Computer Use (NCT00177320) | University of Pittsburgh | 2005-03-01 |
| Study Evaluating the Efficacy of Enbrel (Etanercept) in Subjects in Japan (NCT00503503) | Wyeth is now a wholly owned subsidiary of Pfizer | 2005-03-01 |